NCT05741632View on ClinicalTrials.gov

Safety Profile Comparison of Undiluted Intracameral Moxifloxacin vs. Levofloxacin in Cataract Surgery

PHASE1CompletedINTERVENTIONAL
Enrollment

68

Participants

Timeline

Start Date

February 1, 2023

Primary Completion Date

March 31, 2023

Study Completion Date

April 1, 2023

Conditions
Cataract
Interventions
DRUG

Moxifloxacin Ophthalmic Solution

Moxifloxacin solution 0.1 cc undiluted, self preserved, injected into intracamera at the end of cataract surgery

DRUG

Levofloxacin Ophthalmic

Levofloxacin solution 0.1 cc undiluted, self preserved, injected into intracamera at the end of cataract surgery

Trial Locations (1)

10430

Fakultas Kedokteran Universitas Indonesia, Jakarta Pusat

Sponsors
All Listed Sponsors
collaborator

Ferron Par Pharmaceuticals

UNKNOWN

lead

Indonesia University

OTHER